A vaccine that works is seen as a game-changer in the battle against Covid-19, which has killed more than 1.15 million worldwide. Photo: AP
Oxford coronavirus vaccine prompts immune response in young and old adults: AstraZeneca
- The vaccine, developed by the University of Oxford, also triggers lower adverse responses among the elderly, AstraZeneca says
- The Oxford/AstraZeneca vaccine is expected to be one of the first large pharmaceutical companies to secure regulatory approval
A vaccine that works is seen as a game-changer in the battle against Covid-19, which has killed more than 1.15 million worldwide. Photo: AP